Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine
Open accessThe DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
During the last decades, hiPSC-derived organoids have been extensively studied and used as in vitro models for several applications among which research studies. They can be considered as organ and tissue prototypes, especially for those difficult to obtain. Moreover, several diseases can be accurately modeled and studied. Hence, patient-derived organoids (PDOs) can be used to predict individual drug responses, thus paving the way toward personalized medicine. Lastly, by applying tissue engineering and 3D printing techniques, organoids could be used in the future to replace or regenerate damaged tissue. In this review, we will focus on hiPSC-derived 3D cultures and their ability to model human diseases with an in-depth analysis of gene editing applications, as well as tumor models. Furthermore, we will highlight the state-of-the-art of organoid facilities that around the world offer know-how and services. This is an increasing trend that shed the light on the need of bridging the publicand the private sector. Hence, in the context of drug discovery, Organoid Factories can offer biobanks of validated 3D organoid models that can be used in collaboration with pharmaceutical companies to speed up the drug screening process. Finally, we will discuss the limitations and the future development that will lead hiPSC-derived technology from bench to bedside, toward personalized medicine, such as maturity, organoid interconnections, costs, reproducibility and standardization, and ethics. hiPSC-derived organoid technology is now passing from a proof-of-principle to real applications in the clinic, also thanks to the applicability of techniques, such as CRISPR/Cas9 genome editing system, material engineering for the scaffolds, or microfluidic systems. The benefits will have a crucial role in the advance of both basic biological and translational research, particularly in the pharmacological field and drug development. In fact, in the near future, 3D organoids will guide the clinical decision-making process, having validated patient-specific drug screening platforms. This is particularly important in the context of rare genetic diseases or when testing cancer treatments that could in principle have severe side effects. Therefore, this technology has enabled the advancement of personalized medicine in a way never seen before.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673 · cited 2×
“The latter is involved in embryonic development and has evident ethical problems that limit their applicability, while human iPSCs (hiPSCs) overcome this limitation as they are usually derived from a skin biopsy or other sources of adult cells and can be reprogrammed to be pluripotent stem cells, through the some repr…”
BackgroundSingle Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204 · cited 1×
“, 2013), adult stem cells (ASCs) (Sato et al., 2009), or embryonic stem cells (ESCs) (Jo et al.”
BackgroundCerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372 · cited 3×
“reported the first protocol to generate cerebral organoids, which included interdependent brain regions, such as the cerebral cortex containing progenitor populations that produce mature cortical neuron subtypes (Lancaster et al., 2013).”
BackgroundReconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Modeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196 · cited 1×
“The derivation process of PSC organoids exploits both the ability of these stem cells to differentiate into several cell types and the organ development process, including spatial patterning and morphogenesis (Clevers 2016; Eiraku, M. et al., 2011; Lancaster et al., 2013).”
BackgroundBrain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure
Qian, X., Nguyen, H. N., Song, M. M., Hadiono, C., Ogden, S. C., Hammack, C., Yao, B., Hamersky, G. R., Jacob, F., Zhong, C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.032 · Cited by 2,127
Self-organizing optic-cup morphogenesis in three-dimensional culture
Eiraku, M., Takata, N., Ishibashi, H., Kawada, M., Sakakura, E., Okuda, S., Sekiguchi, K., Adachi, T., & Sasai, Y. (2011) · Nature · doi:10.1038/nature09941 · Cited by 2,001
Cells of the adult human heart
Litviňuková, M., Talavera-López, C., Maatz, H., Reichart, D., Worth, C. L., Lindberg, E. L., Kanda, M., Polanski, K., Heinig, M., Lee, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2797-4 · Cited by 1,729 · cited 1×
“It has been recently reported that 11 cardiac cell types directly constitute the heart, such as atrial cardiomyocytes, ventricular cardiomyocytes, fibroblasts, endothelial cells, pericytes, smooth muscle cells, immune cells (myeloid and lymphoid), adipocytes, mesothelial cells and neuronal cells (Litviňuková et al., 2…”
BackgroundHuman primary liver cancer–derived organoid cultures for disease modeling and drug screening
Broutier, L., Mastrogiovanni, G., Verstegen, M. M., Francies, H. E., Gavarró, L. M., Bradshaw, C. R., Allen, G. E., Arnes-Benito, R., Sidorova, O., Gaspersz, M. P., et al. (2017) · Nature Medicine · doi:10.1038/nm.4438 · Cited by 1,471 · cited 1×
“Drug screening and discovery, being a scalable and robust technology, to study the efficacy and side effects of a large number of molecules simultaneously and with great precision (Broutier et al., 2017; Medle et al., 2022) 4.”
BackgroundAn in vivo model of functional and vascularized human brain organoids
Mansour, A. A., Gonçalves, J. T., Bloyd, C. W., Li, H., Fernandes, S., Quang, D., Johnston, S., Parylak, S. L., Jin, X., & Gage, F. H. (2018) · Nature Biotechnology · doi:10.1038/nbt.4127 · Cited by 1,211 · cited 2×
“Although there are studies on brain or vascular organoids reporting that they maintain their functionality through vascularization in vivo (Mansour et al., 2018; Wimmer et al., 2019), only Lee and collaborators demonstrated for the first time that human heart organoids has been implanted in vivo…”
BackgroundSex Differences in Pharmacokinetics and Pharmacodynamics
Soldin, O. P., & Mattison, D. R. (2009) · Clinical Pharmacokinetics · doi:10.2165/00003088-200948030-00001 · Cited by 1,163 · cited 1×
“In addition, there is a need to confirm drug safety in both male and female humans (Soldin and Mattison, 2009) along with high-throughput screening of a wide range of drugs and compounds for different purposes, including the development of novel contraceptive agents and vaccines, drug screening for infectious diseases…”
BackgroundJacob, F., Salinas, R. D., Zhang, D. Y., Nguyen, P. T. T., Schnoll, J. G., Wong, S. Z. H., Thokala, R., Sheikh, S., Saxena, D., Prokop, S., et al. (2020) · Cell · doi:10.1016/j.cell.2019.11.036 · Cited by 1,149 · cited 1×
“Biobanking, as samples obtained from patients can be used to generate patient-derived organoids (PDOs) and stored as a resource for future research (Takebe et al., 2018; Jacob et al., 2020); 5.”
BackgroundAndrew, S. E., Paul Goldberg, Y., Kremer, B., Telenius, H., Theilmann, J., Adam, S., Starr, E., Squitieri, F., Lin, B., Kalchman, M. A., et al. (1993) · Nature Genetics · doi:10.1038/ng0893-398 · Cited by 1,129
Lin, Y.-T., Seo, J., Gao, F., Feldman, H. M., Wen, H.-L., Penney, J., Cam, H. P., Gjoneska, E., Raja, W. K., Cheng, J., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.008 · Cited by 1,125
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Tiriac, H., Belleau, P., Engle, D. D., Plenker, D., Deschênes, A., Somerville, T. D. D., Froeling, F. E. M., Burkhart, R. A., Denroche, R. E., Jang, G.-H., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0349 · Cited by 1,092
Advances in organ-on-a-chip engineering
Zhang, B., Korolj, A., Lai, B. F. L., & Radisic, M. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0034-7 · Cited by 1,017
Trujillo, C. A., Gao, R., Negraes, P. D., Gu, J., Buchanan, J., Preissl, S., Wang, A., Wu, W., Haddad, G. G., Chaim, I. A., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.08.002 · Cited by 974
Aicardi–Goutières syndrome and the type I interferonopathies
Crow, Y. J., & Manel, N. (2015) · Nature Reviews Immunology · doi:10.1038/nri3850 · Cited by 925 · cited 1×
“For example, the mutation of the TREX1 gene causes Aicardi Goutieres Syndrome (AGS) type I, which is characterized by dramatic neuronal loss and leads to lifelong disability (Crow and Manel, 2015).”
BackgroundKim, H. J., Li, H., Collins, J. J., & Ingber, D. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522193112 · Cited by 922
Engineering of functional, perfusable 3D microvascular networks on a chip
Kim, S., Lee, H., Chung, M., & Jeon, N. L. (2013) · Lab on a Chip · doi:10.1039/c3lc41320a · Cited by 872 · cited 1×
“The model reproduced perfusable blood vessels (Kim et al., 2013; Hasan A et al., 2015; Wang et al., 2016; Chen M.B. et al., 2017), thus addressing the need of giving the right amount of nutrient supply and expanding the life span with respect to standard organoid models.”
MethodModelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs
Lee, G., Papapetrou, E. P., Kim, H., Chambers, S. M., Tomishima, M. J., Fasano, C. A., Ganat, Y. M., Menon, J., Shimizu, F., Viale, A., et al. (2009) · Nature · doi:10.1038/nature08320 · Cited by 867 · cited 1×
“For example, Lee and coworkers (Lee et al., 2009) derived peripheral neurons from hiPSCs of a patient with Familial Dysautonomia (FD), a rare inherited sensory and autonomic neuropathy caused by point mutation of the IKBKAP gene.”
BackgroundJo, J., Xiao, Y., Sun, A. X., Cukuroglu, E., Tran, H.-D., Göke, J., Tan, Z. Y., Saw, T. Y., Tan, C.-P., Lokman, H., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.07.005 · Cited by 861 · cited 1×
“, 2009), or embryonic stem cells (ESCs) (Jo et al., 2016).”
BackgroundIn Vitro Expansion of Human Gastric Epithelial Stem Cells and Their Responses to Bacterial Infection
Bartfeld, S., Bayram, T., van de Wetering, M., Huch, M., Begthel, H., Kujala, P., Vries, R., Peters, P. J., & Clevers, H. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.09.042 · Cited by 820
Human blood vessel organoids as a model of diabetic vasculopathy
Wimmer, R. A., Leopoldi, A., Aichinger, M., Wick, N., Hantusch, B., Novatchkova, M., Taubenschmid, J., Hämmerle, M., Esk, C., Bagley, J. A., et al. (2019) · Nature · doi:10.1038/s41586-018-0858-8 · Cited by 803 · cited 1×
“Although there are studies on brain or vascular organoids reporting that they maintain their functionality through vascularization in vivo (Mansour et al., 2018; Wimmer et al., 2019), only Lee and collaborators demonstrated for the first time that human heart organoids has been implanted in vivo into nude mice and tha…”
BackgroundWeaver, V. M., Lelièvre, S., Lakins, J. N., Chrenek, M. A., Jones, J. C. R., Giancotti, F., Werb, Z., & Bissell, M. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00125-3 · Cited by 793 · cited 1×
“These interactions are responsible for cell differentiation, proliferation, vitality, expression of genes and proteins, responsiveness to stimuli, drug metabolism, and other cellular functions (Mseka et al., 2007; Weaver et al., 2002; Meyers et al., 2003).”
BackgroundFreedman, B. S., Brooks, C. R., Lam, A. Q., Fu, H., Morizane, R., Agrawal, V., Saad, A. F., Li, M. K., Hughes, M. R., Werff, R. V., et al. (2015) · Nature Communications · doi:10.1038/ncomms9715 · Cited by 780 · cited 2×
“Currently, some of the best-known applications of CRISPR-Cas9 technology on organoids include cancer organoid models (Hendriks et al., 2020), intestinal organoids for the study of Cystic Fibrosis (CF) (Geurts et al., 2021), and DGAT1 gene regulation (Schene et al., 2020), kidney organoids for the study of Autosomal Do…”
BackgroundHuman iPSC-based modeling of late-onset disease via progerin-induced aging
Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., Mandal, P. K., Vera, E., Shim, J.-W., Kriks, S., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.006 · Cited by 777
Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer
Yao, Y., Xu, X., Yang, L., Zhu, J., Wan, J., Shen, L., Xia, F., Fu, G., Deng, Y., Pan, M., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2019.10.010 · Cited by 755
Workman, M. J., Mahe, M. M., Trisno, S., Poling, H. M., Watson, C. L., Sundaram, N., Chang, C.-F., Schiesser, J., Aubert, P., Stanley, E. G., et al. (2017) · Nature Medicine · doi:10.1038/nm.4233 · Cited by 626
Gene expression perturbation in vitro—A growing case for three-dimensional (3D) culture systems
Birgersdotter, A., Sandberg, R., & Ernberg, I. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.06.009 · Cited by 591 · cited 1×
“Furthermore, it has been observed that the 2D system changes the gene expression and splicing, topology, and biochemistry of the cell (Birgersdotter et al., 2005; Li et al., 2006).”
BackgroundCorrò, C., Novellasdemunt, L., & Li, V. S. W. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00120.2020 · Cited by 561 · cited 1×
“Organoids were first developed in 1987 (Corrò et al., 2020), after two important scientific successes: the application of collagenase for tissue digestion in the 1950s and the isolation of Matrigel in the 1980s (Xia et al.”
BackgroundDekkers, J. F., Berkers, G., Kruisselbrink, E., Vonk, A., de Jonge, H. R., Janssens, H. M., Bronsveld, I., van de Graaf, E. A., Nieuwenhuis, E. E. S., Houwen, R. H. J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad8278 · Cited by 548 · cited 1×
“An important example of a patient-specific efficacy drug test, conducted in the laboratory, was reported by Dekkers and others (Dekkers et al., 2016).”
BackgroundModeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids
Ouchi, R., Togo, S., Kimura, M., Shinozawa, T., Koido, M., Koike, H., Thompson, W., Karns, R. A., Mayhew, C. N., McGrath, P. S., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.05.007 · Cited by 537
Lewis-Israeli, Y. R., Wasserman, A. H., Gabalski, M. A., Volmert, B. D., Ming, Y., Ball, K. A., Yang, W., Zou, J., Ni, G., Pajares, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25329-5 · Cited by 536 · cited 1×
“developed heart organoids that mimic the cardiac structure, reflecting the vascular network inside the organoid without external interference (Lewis-Israeli et al., 2021).”
BackgroundIdentification of SARS-CoV-2 inhibitors using lung and colonic organoids
Han, Y., Duan, X., Yang, L., Nilsson-Payant, B. E., Wang, P., Duan, F., Tang, X., Yaron, T. M., Zhang, T., Uhl, S., et al. (2021) · Nature · doi:10.1038/s41586-020-2901-9 · Cited by 530
The Flaws and Human Harms of Animal Experimentation
AKHTAR, A. (2015) · Cambridge Quarterly of Healthcare Ethics · doi:10.1017/s0963180115000079 · Cited by 527 · cited 2×
“Although to date, animal models are the gold standard and a mandatory step for drug screening tests and the translation of the compounds from the bench to the clinic, in vitro and in vivo tests in animals are still poorly predictive of the efficacy and safety in humans (Akhtar, 2015).”
BackgroundOrganoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling
Skardal, A., Shupe, T., & Atala, A. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.07.003 · Cited by 512
Boretto, M., Maenhoudt, N., Luo, X., Hennes, A., Boeckx, B., Bui, B., Heremans, R., Perneel, L., Kobayashi, H., Van Zundert, I., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0360-z · Cited by 503
hESC-Derived Thalamic Organoids Form Reciprocal Projections When Fused with Cortical Organoids
Xiang, Y., Tanaka, Y., Cakir, B., Patterson, B., Kim, K.-Y., Sun, P., Kang, Y.-J., Zhong, M., Liu, X., Patra, P., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.12.015 · Cited by 485 · cited 1×
“Examples of assembloids are the combination of organoids resembling different regions of the brain, such as dorsal and ventral forebrain, or thalamic and cortical organoids to study the spatial organization and functional interaction between the various subtypes of cells (Xiang et al., 2019).”
BackgroundRecapitulating macro-scale tissue self-organization through organoid bioprinting
Brassard, J. A., Nikolaev, M., Hübscher, T., Hofer, M., & Lutolf, M. P. (2021) · Nature Materials · doi:10.1038/s41563-020-00803-5 · Cited by 469
Ruan, J.-L., Tulloch, N. L., Razumova, M. V., Saiget, M., Muskheli, V., Pabon, L., Reinecke, H., Regnier, M., & Murry, C. E. (2016) · Circulation · doi:10.1161/circulationaha.114.014998 · Cited by 467
ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update
Lovell-Badge, R., Anthony, E., Barker, R. A., Bubela, T., Brivanlou, A. H., Carpenter, M., Charo, R. A., Clark, A., Clayton, E., Cong, Y., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.05.012 · Cited by 398
Self‐organized developmental patterning and differentiation in cerebral organoids
Renner, M., Lancaster, M. A., Bian, S., Choi, H., Ku, T., Peer, A., Chung, K., & Knoblich, J. A. (2017) · The EMBO Journal · doi:10.15252/embj.201694700 · Cited by 389 · cited 2×
“…embryonic stages of development has allowed the replication of key steps in organogenesis such as spatial organization of the heart, the brain, the gastrointestinal tract and other organs (Rossi et al., 2019; Renner et al., 2017; Finkbeiner, S. R., et al., 2015; McCracken, K. W. et al., 2014).”
BackgroundModelling Cryptosporidium infection in human small intestinal and lung organoids
Heo, I., Dutta, D., Schaefer, D. A., Iakobachvili, N., Artegiani, B., Sachs, N., Boonekamp, K. E., Bowden, G., Hendrickx, A. P. A., Willems, R. J. L., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0177-8 · Cited by 389
Chen, M. B., Whisler, J. A., Fröse, J., Yu, C., Shin, Y., & Kamm, R. D. (2017) · Nature Protocols · doi:10.1038/nprot.2017.018 · Cited by 385
Disease modelling in human organoids
Lancaster, M. A., & Huch, M. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039347 · Cited by 377 · cited 1×
“Disease modeling, to understand the mechanisms of human diseases such as infectious diseases, inherited genetic diseases, and cancer using multi-omics and drug screening analyses (Lancaster and Huch, 2019); 6.”
BackgroundInduced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development
Karagiannis, P., Takahashi, K., Saito, M., Yoshida, Y., Okita, K., Watanabe, A., Inoue, H., Yamashita, J. K., Todani, M., Nakagawa, M., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00039.2017 · Cited by 368 · cited 1×
“Moreover, hiPSC-derived organoids are able to self-renew and be stable over a long period of time (Karagiannis et al., 2019).”
BackgroundHuman brain organoid-on-a-chip to model prenatal nicotine exposure
Wang, Y., Wang, L., Zhu, Y., & Qin, J. (2018) · Lab on a Chip · doi:10.1039/c7lc01084b · Cited by 325
Shirure, V. S., Bi, Y., Curtis, M. B., Lezia, A., Goedegebuure, M. M., Goedegebuure, S. P., Aft, R., Fields, R. C., & George, S. C. (2018) · Lab on a Chip · doi:10.1039/c8lc00596f · Cited by 316
3D bioprinting for drug discovery and development in pharmaceutics
Peng, W., Datta, P., Ayan, B., Ozbolat, V., Sosnoski, D., & Ozbolat, I. T. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.05.025 · Cited by 313
Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis
Berkers, G., van Mourik, P., Vonk, A. M., Kruisselbrink, E., Dekkers, J. F., de Winter-de Groot, K. M., Arets, H. G. M., Marck-van der Wilt, R. E. P., Dijkema, J. S., Vanderschuren, M. M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.068 · Cited by 310
3D printing: an emerging tool for novel microfluidics and lab-on-a-chip applications
Yazdi, A. A., Popma, A., Wong, W., Nguyen, T., Pan, Y., & Xu, J. (2016) · Microfluidics and Nanofluidics · doi:10.1007/s10404-016-1715-4 · Cited by 307
Capturing Cardiogenesis in Gastruloids
Rossi, G., Broguiere, N., Miyamoto, M., Boni, A., Guiet, R., Girgin, M., Kelly, R. G., Kwon, C., & Lutolf, M. P. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2020.10.013 · Cited by 306
Multi-lineage human iPSC-derived platforms for disease modeling and drug discovery
Sharma, A., Sances, S., Workman, M. J., & Svendsen, C. N. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.02.011 · Cited by 296
Wang, P., Mokhtari, R., Pedrosa, E., Kirschenbaum, M., Bayrak, C., Zheng, D., & Lachman, H. M. (2017) · Molecular Autism · doi:10.1186/s13229-017-0124-1 · Cited by 257 · cited 2×
“, 2021), the CHD8 gene involved in Autism Spectrum Disorders (ASD) (Wang et al., 2017), and GM1 Gangliosidosis (Latour et al.”
BackgroundWang, X., Phan, D. T. T., Sobrino, A., George, S. C., Hughes, C. C. W., & Lee, A. P. (2016) · Lab on a Chip · doi:10.1039/c5lc01050k · Cited by 251 · cited 1×
“The model reproduced perfusable blood vessels (Kim et al., 2013; Hasan A et al., 2015; Wang et al., 2016; Chen M.B. et al., 2017), thus addressing the need of giving the right amount of nutrient supply and expanding the life span with respect to standard organoid models.”
MethodFinkbeiner, S. R., Hill, D. R., Altheim, C. H., Dedhia, P. H., Taylor, M. J., Tsai, Y.-H., Chin, A. M., Mahe, M. M., Watson, C. L., Freeman, J. J., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.04.010 · Cited by 247
Prime editing for functional repair in patient-derived disease models
Schene, I. F., Joore, I. P., Oka, R., Mokry, M., van Vugt, A. H. M., van Boxtel, R., van der Doef, H. P. J., van der Laan, L. J. W., Verstegen, M. M. A., van Hasselt, P. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19136-7 · Cited by 237 · cited 2×
“…models (Hendriks et al., 2020), intestinal organoids for the study of Cystic Fibrosis (CF) (Geurts et al., 2021), and DGAT1 gene regulation (Schene et al., 2020), kidney organoids for the study of Autosomal Dominant Polycystic Kidney Disease (ADPKD) (Freedman et al., 2015; Kuraoka et al.,…”
BackgroundPotential for Control of Signaling Pathways via Cell Size and Shape
Meyers, J., Craig, J., & Odde, D. J. (2006) · Current Biology · doi:10.1016/j.cub.2006.07.056 · Cited by 232 · cited 1×
“These interactions are responsible for cell differentiation, proliferation, vitality, expression of genes and proteins, responsiveness to stimuli, drug metabolism, and other cellular functions (Mseka et al., 2007; Weaver et al., 2002; Meyers et al., 2003).”
BackgroundPromises and challenges of organoid-guided precision medicine
Bose, S., Clevers, H., & Shen, X. (2021) · Med · doi:10.1016/j.medj.2021.08.005 · Cited by 213
Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer
Lõhmussaar, K., Oka, R., Espejo Valle-Inclan, J., Smits, M. H. H., Wardak, H., Korving, J., Begthel, H., Proost, N., van de Ven, M., Kranenburg, O. W., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.03.012 · Cited by 211
Assembling human brain organoids
Paşca, S. P. (2019) · Science · doi:10.1126/science.aau5729 · Cited by 208 · cited 1×
“The direction in which research in this field is heading is the development of assembloids: manually forcing the union of organoids or fusing different cell types so as to unite multiple systems in one platform, possibly using morphogenic gradients as “organizers” of substructures (Pasca, 2019).”
BackgroundA 3D human lung-on-a-chip model for nanotoxicity testing
Zhang, M., Xu, C., Jiang, L., & Qin, J. (2018) · Toxicology Research · doi:10.1039/c8tx00156a · Cited by 207
TTC7A mutations disrupt intestinal epithelial apicobasal polarity
Bigorgne, A. E., Farin, H. F., Lemoine, R., Mahlaoui, N., Lambert, N., Gil, M., Schulz, A., Philippet, P., Schlesser, P., Abrahamsen, T. G., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71471 · Cited by 200
Use and application of 3D-organoid technology
Artegiani, B., & Clevers, H. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy187 · Cited by 193 · cited 2×
“Examples of this type of application are the study of the ZIKA virus on brain organoids and the use of intestinal organoids to study enteric viruses or the interaction between microbiota and intestinal epithelium (Artegiani and Clevers, 2018).”
BackgroundCRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids
Hendriks, D., Clevers, H., & Artegiani, B. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.10.014 · Cited by 192 · cited 1×
“Currently, some of the best-known applications of CRISPR-Cas9 technology on organoids include cancer organoid models (Hendriks et al., 2020), intestinal organoids for the study of Cystic Fibrosis (CF) (Geurts et al.”
BackgroundEthical issues related to brain organoid research
Hyun, I., Scharf-Deering, J. C., & Lunshof, J. E. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146653 · Cited by 183
Modeling and Rescue of RP2 Retinitis Pigmentosa Using iPSC-Derived Retinal Organoids
Lane, A., Jovanovic, K., Shortall, C., Ottaviani, D., Panes, A. B., Schwarz, N., Guarascio, R., Hayes, M. J., Palfi, A., Chadderton, N., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.05.007 · Cited by 181
Loss of Syntaxin 3 Causes Variant Microvillus Inclusion Disease
Wiegerinck, C. L., Janecke, A. R., Schneeberger, K., Vogel, G. F., van Haaften–Visser, D. Y., Escher, J. C., Adam, R., Thöni, C. E., Pfaller, K., Jordan, A. J., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.002 · Cited by 180 · cited 1×
“Microvillus inclusion disease (STX3 gene) (Wiegerinck et al., 2014)*”
Zhou, Z., Cong, L., & Cong, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.762184 · Cited by 178
Organoids to model liver disease
Nuciforo, S., & Heim, M. H. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2020.100198 · Cited by 164
Retinal organoids: a window into human retinal development
O'Hara-Wright, M., & Gonzalez-Cordero, A. (2020) · Development · doi:10.1242/dev.189746 · Cited by 163 · cited 1×
“, 2021), retina (O’Hara-Wright and Gonzalez-Cordero, 2020), heart (Lee et al.”
Robust, Long-Term Culture of Endoderm-Derived Hepatic Organoids for Disease Modeling
Akbari, S., Sevinç, G. G., Ersoy, N., Basak, O., Kaplan, K., Sevinç, K., Ozel, E., Sengun, B., Enustun, E., Ozcimen, B., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.08.007 · Cited by 157
Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids
Geurts, M. H., de Poel, E., Pleguezuelos-Manzano, C., Oka, R., Carrillo, L., Andersson-Rolf, A., Boretto, M., Brunsveld, J. E., van Boxtel, R., Beekman, J. M., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202000940 · Cited by 151 · cited 1×
“, 2020), intestinal organoids for the study of Cystic Fibrosis (CF) (Geurts et al., 2021), and DGAT1 gene regulation (Schene et al.”
BackgroundBrain Organoids and the Study of Neurodevelopment
Trujillo, C. A., & Muotri, A. R. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.09.005 · Cited by 149 · cited 2×
“The only non-invasive techniques that allowed to study the neurodevelopment were ultrasound imaging, animal models, or abortus material (Trujillo and Muotri, 2018).”
BackgroundMethodOrganoid-based modeling of intestinal development, regeneration, and repair
Sprangers, J., Zaalberg, I. C., & Maurice, M. M. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00665-z · Cited by 148 · cited 1×
“, 2022), gut (Sprangers et al., 2020), kidneys (van den Berg et al.”
BackgroundEngineering of human cardiac muscle electromechanically matured to an adult-like phenotype
Ronaldson-Bouchard, K., Yeager, K., Teles, D., Chen, T., Ma, S., Song, L., Morikawa, K., Wobma, H. M., Vasciaveo, A., Ruiz, E. C., et al. (2019) · Nature Protocols · doi:10.1038/s41596-019-0189-8 · Cited by 144
Tang, X.-Y., Xu, L., Wang, J., Hong, Y., Wang, Y., Zhu, Q., Wang, D., Zhang, X.-Y., Liu, C.-Y., Fang, K.-H., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci135763 · Cited by 143 · cited 1×
“, 2020), and brain organoids for the study of Trisomy 21 (Tang et al., 2021), the CHD8 gene involved in Autism Spectrum Disorders (ASD) (Wang et al.”
BackgroundA multilayered microfluidic blood vessel-like structure
Hasan, A., Paul, A., Memic, A., & Khademhosseini, A. (2015) · Biomedical Microdevices · doi:10.1007/s10544-015-9993-2 · Cited by 139
Chapman, K. L., Holzgrefe, H., Black, L. E., Brown, M., Chellman, G., Copeman, C., Couch, J., Creton, S., Gehen, S., Hoberman, A., et al. (2013) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2013.03.001 · Cited by 136 · cited 1×
“In addition, there is a need to confirm drug safety in both male and female humans (Soldin and Mattison, 2009) along with high-throughput screening of a wide range of drugs and compounds for different purposes, including the development of novel contraceptive agents and vaccines, drug screening for infectious diseases…”
BackgroundSung, J. H., Srinivasan, B., Esch, M. B., McLamb, W. T., Bernabini, C., Shuler, M. L., & Hickman, J. J. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214529397 · Cited by 132 · cited 1×
“Moreover, a higher level of complexity is pursued by the Sung group, pioneer in this field, that aim to combine different organoids and organoids-on-a-chip in order to get even closer to the reproduction of the human body, also called “human-on-a-chip”, with the purpose of developing a comprehensive model that could a…”
BackgroundVonk, A. M., van Mourik, P., Ramalho, A. S., Silva, I. A. L., Statia, M., Kruisselbrink, E., Suen, S. W. F., Dekkers, J. F., Vleggaar, F. P., Houwen, R. H. J., et al. (2020) · STAR Protocols · doi:10.1016/j.xpro.2020.100019 · Cited by 128
de Jong, J. O., Llapashtica, C., Genestine, M., Strauss, K., Provenzano, F., Sun, Y., Zhu, H., Cortese, G. P., Brundu, F., Brigatti, K. W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24358-4 · Cited by 120
Bioprinting of 3D tissues/organs combined with microfluidics
Ma, J., Wang, Y., & Liu, J. (2018) · RSC Advances · doi:10.1039/c8ra03022g · Cited by 113
ALS disrupts spinal motor neuron maturation and aging pathways within gene co-expression networks
Ho, R., Sances, S., Gowing, G., Amoroso, M. W., O'Rourke, J. G., Sahabian, A., Wichterle, H., Baloh, R. H., Sareen, D., & Svendsen, C. N. (2016) · Nature Neuroscience · doi:10.1038/nn.4345 · Cited by 100 · cited 1×
“However, it is possible to force organoid maturation by adding complex factors to the culture media or by inducing overexpression of aging genes (Miller et al., 2013; Ho et al., 2016).”
BackgroundErgir, E., Oliver-De La Cruz, J., Fernandes, S., Cassani, M., Niro, F., Pereira-Sousa, D., Vrbský, J., Vinarský, V., Perestrelo, A. R., Debellis, D., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-22225-w · Cited by 99 · cited 1×
“The authors demonstrated that this model could be used to study chemotherapy-induced cardiotoxicity (Ergir et al., 2022).”
BackgroundLi, C., Kato, M., Shiue, L., Shively, J. E., Ares, M., & Lin, R.-J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2593 · Cited by 97
Soroka, C. J., Assis, D. N., Alrabadi, L. S., Roberts, S., Cusack, L., Jaffe, A. B., & Boyer, J. L. (2019) · Hepatology · doi:10.1002/hep.30470 · Cited by 97
Mseka, T., Bamburg, J. R., & Cramer, L. P. (2007) · Journal of Cell Science · doi:10.1242/jcs.017640 · Cited by 96 · cited 1×
“These interactions are responsible for cell differentiation, proliferation, vitality, expression of genes and proteins, responsiveness to stimuli, drug metabolism, and other cellular functions (Mseka et al., 2007; Weaver et al., 2002; Meyers et al., 2003).”
BackgroundKuraoka, S., Tanigawa, S., Taguchi, A., Hotta, A., Nakazato, H., Osafune, K., Kobayashi, A., & Nishinakamura, R. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020030378 · Cited by 93 · cited 2×
“Currently, some of the best-known applications of CRISPR-Cas9 technology on organoids include cancer organoid models (Hendriks et al., 2020), intestinal organoids for the study of Cystic Fibrosis (CF) (Geurts et al., 2021), and DGAT1 gene regulation (Schene et al., 2020), kidney organoids for the study of Autosomal Do…”
BackgroundRadhakrishnan, J., Varadaraj, S., Dash, S. K., Sharma, A., & Verma, R. S. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.03.002 · Cited by 91
Clinical application of a lung cancer organoid (tumoroid) culture system
Yokota, E., Iwai, M., Yukawa, T., Yoshida, M., Naomoto, Y., Haisa, M., Monobe, Y., Takigawa, N., Guo, M., Maeda, Y., et al. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00166-3 · Cited by 91
Organoids are promising tools for species‐specific in vitro toxicological studies
Augustyniak, J., Bertero, A., Coccini, T., Baderna, D., Buzanska, L., & Caloni, F. (2019) · Journal of Applied Toxicology · doi:10.1002/jat.3815 · Cited by 85
de Winter-de Groot, K. M., Janssens, H. M., van Uum, R. T., Dekkers, J. F., Berkers, G., Vonk, A., Kruisselbrink, E., Oppelaar, H., Vries, R., Clevers, H., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.02529-2017 · Cited by 81
Tristan, C. A., Ormanoglu, P., Slamecka, J., Malley, C., Chu, P.-H., Jovanovic, V. M., Gedik, Y., Jethmalani, Y., Bonney, C., Barnaeva, E., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.11.004 · Cited by 80
Generation of human iPSCs derived heart organoids structurally and functionally similar to heart
Lee, S.-G., Kim, Y.-J., Son, M.-Y., Oh, M.-S., Kim, J., Ryu, B., Kang, K.-R., Baek, J., Chung, G., Woo, D. H., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121860 · Cited by 80 · cited 3×
“, 2019), only Lee and collaborators demonstrated for the first time that human heart organoids has been implanted in vivo into nude mice and that beating is maintained through in vivo vascularization (Lee et al., 2022).”
BackgroundInfluentialOrganoid technology in cancer precision medicine
Xia, X., Li, F., He, J., Aji, R., & Gao, D. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.039 · Cited by 76 · cited 2×
“, 2020), after two important scientific successes: the application of collagenase for tissue digestion in the 1950s and the isolation of Matrigel in the 1980s (Xia et al., 2019).”
BackgroundBrannen, K. C., Chapin, R. E., Jacobs, A. C., & Green, M. L. (2016) · ILAR Journal · doi:10.1093/ilar/ilw026 · Cited by 72 · cited 1×
“In addition, there is a need to confirm drug safety in both male and female humans (Soldin and Mattison, 2009) along with high-throughput screening of a wide range of drugs and compounds for different purposes, including the development of novel contraceptive agents and vaccines, drug screening for infectious diseases…”
BackgroundRecent advances in human respiratory epithelium models for drug discovery
Yaqub, N., Wayne, G. J., Birchall, M., & Song, W. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107832 · Cited by 67 · cited 1×
“In the United Kingdom, the use of organoids as a drug screening platform led to an overall reduction in the number of animals used for scientific purposes by 7 percent annually in 2018 (Yaqub et al., 2022).”
BackgroundDuan, X., Tang, X., Nair, M. S., Zhang, T., Qiu, Y., Zhang, W., Wang, P., Huang, Y., Xiang, J., Wang, H., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109920 · Cited by 66 · cited 1×
“Although common 2D human cell cultures are permissive to infection in vitro, they cannot faithfully reproduce the human pathophysiology (Duan et al., 2021). hLORGs have been validated instead to be useful in vitromodels to simulate infections and screen new compounds.”
BackgroundOrganoid Center Strategies for Accelerating Clinical Translation
Takebe, T., Wells, J. M., Helmrath, M. A., & Zorn, A. M. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.008 · Cited by 64 · cited 1×
“Biobanking, as samples obtained from patients can be used to generate patient-derived organoids (PDOs) and stored as a resource for future research (Takebe et al., 2018; Jacob et al., 2020); 5.”
BackgroundGarcia, V. J., Rushton, D. J., Tom, C. M., Allen, N. D., Kemp, P. J., Svendsen, C. N., & Mattis, V. B. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00669 · Cited by 62
Latour, Y. L., Yoon, R., Thomas, S., Grant, C. L., Li, C., Sena‐Esteves, M., Allende, M. L., Proia, R. L., & Tifft, C. J. (2019) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2019.100513 · Cited by 62
van den Berg, C. W., Koudijs, A., Ritsma, L., & Rabelink, T. J. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019060573 · Cited by 62
Woo, D.-H., Chen, Q., Yang, T.-L. B., Glineburg, M. R., Hoge, C., Leu, N. A., Johnson, F. B., & Lengner, C. J. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.05.024 · Cited by 60 · cited 1×
“Dyskeratosis congenital (DKC1 gene) (Woo et al., 2016)*”
Automated Cell Culture Systems and Their Applications to Human Pluripotent Stem Cell Studies
Daniszewski, M., Crombie, D. E., Henderson, R., Liang, H. H., Wong, R. C. B., Hewitt, A. W., & Pébay, A. (2018) · SLAS Technology · doi:10.1177/2472630317712220 · Cited by 57
Shiota, J., Samuelson, L. C., & Razumilava, N. (2021) · Hepatology · doi:10.1002/hep.31772 · Cited by 56 · cited 1×
“Liver Alagille syndrome (JAG1 gene) (Shiota et al., 2021)*”
Agboola, O. S., Hu, X., Shan, Z., Wu, Y., & Lei, L. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02369-8 · Cited by 56 · cited 1×
“, 2020), brain (Agboola et al., 2021), retina (O’Hara-Wright and Gonzalez-Cordero, 2020), heart (Lee et al.”
Intestinal organoids to model cystic fibrosis
van Mourik, P., Beekman, J. M., & van der Ent, C. K. (2019) · European Respiratory Journal · doi:10.1183/13993003.02379-2018 · Cited by 54
Modeling rare diseases with induced pluripotent stem cell technology
Anderson, R. H., & Francis, K. R. (2018) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2018.01.001 · Cited by 53 · cited 1×
“The use of organoids as in vitro models is particularly useful in the context of rare genetic diseases (Anderson and Francis, 2018).”
BackgroundBranco, M. A., Dias, T. P., Cabral, J. M. S., Pinto-do-Ó, P., & Diogo, M. M. (2022) · Nature Communications · doi:10.1038/s41467-022-34730-7 · Cited by 50 · cited 1×
“Most recently, Branco and others developed a self-organized heart organoid containing an epicardium-like layer that entirely envelop a myocardium-like tissue enabling further insights into heart organogenesis and the development of myocardial-epicardial interaction (Branco et al., 2022).”
BackgroundBase editing-mediated splicing correction therapy for spinal muscular atrophy
Lin, X., Chen, H., Lu, Y., Hong, S., Hu, X., Gao, Y., Lai, L., Li, J.-J., Wang, Z., Ying, W., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0304-y · Cited by 48 · cited 2×
“For example, CRISPRbased editing was used to convert SMN2 to an SMN1-like gene in hiPSCs derived from patients with Spinal Muscular Atrophy (SMA) caused by homozygous SMN1 gene deletions.”
BackgroundMedle, B., Sjödahl, G., Eriksson, P., Liedberg, F., Höglund, M., & Bernardo, C. (2022) · Cancers · doi:10.3390/cancers14092062 · Cited by 47 · cited 1×
“Drug screening and discovery, being a scalable and robust technology, to study the efficacy and side effects of a large number of molecules simultaneously and with great precision (Broutier et al., 2017; Medle et al., 2022) 4.”
BackgroundA suspension technique for efficient large-scale cancer organoid culturing and perturbation screens
Price, S., Bhosle, S., Gonçalves, E., Li, X., McClurg, D. P., Barthorpe, S., Beck, A., Hall, C., Lightfoot, H., Farrow, L., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09508-y · Cited by 45 · cited 1×
“In this study, they tested the sensitivity of organoid models to 72 anti-cancer drugs from three different cancer types, monitoring global and disease-relevant molecular changes and phenotypes including drug sensitivity and genetic dependencies (Price et al., 2022).”
MethodTwo Different Therapeutic Approaches for SARS-CoV-2 in hiPSCs-Derived Lung Organoids
Spitalieri, P., Centofanti, F., Murdocca, M., Scioli, M. G., Latini, A., Cesare, S. D., Citro, G., Rossi, A., Orlandi, A., Miersch, S., et al. (2022) · Cells · doi:10.3390/cells11071235 · Cited by 32
Self-citationAdult stem cells in neural repair: Current options, limitations and perspectives
Mariano, E. D. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i2.477 · Cited by 31 · cited 1×
“On the contrary, the major drawback of organoids derived from hASCs, organ-specific resident stem cells, is that they can be only composed of the cell types belonging to the original tissue, and consequently the development of these organoids is limited to the accessibility and availability of the hASCs (Mariano et al…”
BackgroundRSV-induced changes in a 3-dimensional organoid model of human fetal lungs
Harford, T. J., Rezaee, F., Dye, B. R., Fan, J., Spence, J. R., & Piedimonte, G. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265094 · Cited by 30 · cited 3×
“Just to cite some of them, so far, the following kind of organoids have been developed: lungs (Han et al., 2021; Spitalieri et al., 2022), liver (Huang et al.”
BackgroundInfluentialSogawa, C. A., Eguchi, T., Namba, Y., Okusha, Y., Aoyama, E., Ohyama, K., & Okamoto, K. (2021) · Cells · doi:10.3390/cells10020344 · Cited by 29
Zhang, Q., Bansal, A. K., Dunbar, K. B., Chang, Y., Zhang, J., Balaji, U., Gu, J., Zhang, X., Podgaetz, E., Pan, Z., et al. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00017.2022 · Cited by 24
Arora, D., Bhunia, B. K., Janani, G., & Mandal, B. B. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.01.010 · Cited by 23
Cromwell, E. F., Sirenko, O., Nikolov, E., Hammer, M., Brock, C. K., Matossian, M. D., Alzoubi, M. S., Collins‐Burow, B. M., & Burow, M. E. (2022) · SLAS DISCOVERY · doi:10.1016/j.slasd.2022.01.006 · Cited by 19
Hirai, H., Liang, X., Sun, Y., Zhang, Y., Zhang, J., Chen, Y. E., Mou, H., Zhao, Y., & Xu, J. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.11.008 · Cited by 18
Patient-Derived Lung Tumoroids—An Emerging Technology in Drug Development and Precision Medicine
Lê, H., Seitlinger, J., Lindner, V., Olland, A., Falcoz, P., Benkirane-Jessel, N., & Quéméneur, É. (2022) · Biomedicines · doi:10.3390/biomedicines10071677 · Cited by 14 · cited 1×
“Quéméneur and others, indeed, successfully included fibroblasts and macrophages in a patient-derived tumoroid observing an enrichment in immune cells and obtaining the expression of the markers of lung adenocarcinoma (Lê et al., 2022).”
BackgroundEmbryonic organoids recapitulate early heart organogenesisPreprint
Rossi, G., Boni, A., Guiet, R., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/802181 · Cited by 13 · cited 2×
“…embryonic stages of development has allowed the replication of key steps in organogenesis such as spatial organization of the heart, the brain, the gastrointestinal tract and other organs (Rossi et al., 2019; Renner et al., 2017; Finkbeiner, S. R., et al., 2015; McCracken, K. W. et al., 2014).”
BackgroundHuang, Y. G., Zhang, S., Weng, J., Huang, D., & Gu, W. (2022) · Open Medicine · doi:10.1515/med-2022-0481 · Cited by 6 · cited 1×
“, 2022), liver (Huang et al., 2022), gut (Sprangers et al.”
Research works printed but not linked: 4
- Harford, 2022, RSV-induced changes in a 3-dimensional organoid model of human fetal lungs, PLoS One, 17, e0265094, 10.1371/journal.pone.0265094 · DOI
- 2022, Snyder institute for chronic diseases
- 2022, Karolinska institutet stem cell organoid
- Zhou, Patient-derived organoids in precision medicine: Drug screening, organoid-on-a-chip and living organoid biobank, Front. Oncol., 11, 5625, 10.3389/fonc.2021.762184 · DOI · Paper page
Cited by
Rahimi Darehbagh, R., Seyedoshohadaei, S. A., Ramezani, R., & Rezaei, N. (2024) · European Journal of Medical Research · doi:10.1186/s40001-024-01987-1 · Cited by 167
“Combining stem cell therapy with other therapeutic approaches, such as Aβ immunization or small molecule inhibitors of Aβ and tau pathology, may provide synergistic benefits [78].”
BackgroundThe Promise and Potential of Brain Organoids
Smirnova, L., & Härtung, T. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302745 · Cited by 101
Zaver, S. A., Sarkar, M. K., Egolf, S., Zou, J., Tiwaa, A., Capell, B. C., Gudjonsson, J. E., & Simpson, C. L. (2023) · JCI Insight · doi:10.1172/jci.insight.170739 · Cited by 38
Sampaio, A. R., Maia, R., Ciardulli, M. C., Santos, H. A., & Sarmento, B. F. C. C. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102053 · Cited by 57
“Differences in genetic background, reprogramming efficiency, and differentiation protocols can lead to inconsistencies in cell behavior, tissue function, and experimental outcomes [173].”
Zhu, Z., Cheng, Y., Liu, X., Ding, W., Liu, J., Ling, Z., & Wu, L. (2025) · Cell Transplantation · doi:10.1177/09636897241303271 · Cited by 33
Metadata
- Authors
- Novelli, G., Spitalieri, P., Murdocca, M., Centanini, E., & Sangiuolo, F.
- Affiliations
- University of Rome Tor Vergata (IT)
- University of Calabria (IT)
- Corresponding author
- Novelli, Giuseppe
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2023-01-09
- Volume
- 10
- Pages
- 1059579-1059579
- ISSN
- 2296-634X (ISSN-L)
- PMC
- PMC9869172
- OpenAlex
- W4313948710
- Cited by
- 43
- References
- 126
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 16 · 2023: 7
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Cell and Developmental Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- human induced pluripotent stem cells, organoids, patient-derived organoids, precision medicine, disease modeling, drug screening, personalized medicine, CRISPR/Cas9 genome editing, tumor models, organoid biobank, 3D organoid culture, tissue engineering, 3D printing, microfluidics, scaffolds, rare genetic disorders, drug repurposing, translational research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.